<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">349686</id>
  <title nil="true"/>
  <common-name>2-[3-[4-(3-methoxyphenyl)piperazin-1-yl]propyl]-2-phenyl-1,3-dihydroindene-1,3-diol</common-name>
  <description>2-[3-[4-(3-methoxyphenyl)piperazin-1-yl]propyl]-2-phenyl-1,3-dihydroindene-1,3-diol is a chemical compound with the formula C29H34N2O3. It has an average molecular weight of 458.60 g/mol.</description>
  <cas>31805-04-6</cas>
  <pubchem-id>208234</pubchem-id>
  <chemical-formula>C29H34N2O3</chemical-formula>
  <weight>458.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T14:20:28Z</created-at>
  <updated-at type="dateTime">2026-08-31T14:20:28Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC=CC(=C1)N2CCN(CC2)CCCC3(C(C4=CC=CC=C4C3O)O)C5=CC=CC=C5</moldb-smiles>
  <moldb-formula>C29H34N2O3</moldb-formula>
  <moldb-inchi>InChI=1S/C29H34N2O3/c1-34-24-12-7-11-23(21-24)31-19-17-30(18-20-31)16-8-15-29(22-9-3-2-4-10-22)27(32)25-13-5-6-14-26(25)28(29)33/h2-7,9-14,21,27-28,32-33H,8,15-20H2,1H3</moldb-inchi>
  <moldb-inchikey>OXKCOEIXUDBCBD-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">458.256943</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM345579</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[3-[4-(3-methoxyphenyl)piperazin-1-yl]propyl]-2-phenyl-1,3-dihydroindene-1,3-diol</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300009</sync-id>
  <structure-inchikey>OXKCOEIXUDBCBD-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000000002080000000000000000000000000000000000000000000000000000000000020000000000010000400010000000000000000000000800000000000000820000000000000000000000400000001010000000000000000000804001001000000004000000010000200000002010000000000000000000010100100404800000080000000000000420000000000010000000000000040000000000000000000002000000008000000000001000000000000a000000800000080000000000000000000000000000000000000000000001000000200000000010000400040008000000040000000010000000000000008000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:47:45Z</structure-indexed-at>
</compound>
